华纳药厂：公司盐酸贝尼地平片拟中标全国药品集中采购

Core Viewpoint - The company has participated in the 11th national centralized drug procurement organized by the National Organization for Drug Procurement, with the intention to win the bid for Benidipine Hydrochloride Tablets, which are used for treating primary hypertension and angina pectoris [1] Group 1: Product and Pricing - The product in question is Benidipine Hydrochloride Tablets, with a specification of 8mg and packaging of 28 tablets per box [1] - The proposed winning bid price is 7.19 yuan per box [1] Group 2: Sales Projections - The company anticipates sales revenue of 166,300 yuan in 2024 and 5,097,600 yuan in the first half of 2025 [1] - If the procurement contract is signed and executed, it will help further expand sales scale, enhance market share, and improve brand influence [1] Group 3: Impact on Future Performance - The successful bid and subsequent contract execution are expected to have a positive impact on the company's future operating performance [1]